Shares of Teladoc Health Inc. (TDOC) soared 5.22% on November 1st, after the telehealth company reported better-than-expected third-quarter earnings results. The stock gained despite analysts' mixed reactions and concerns over Teladoc's revenue outlook.
For the third quarter, Teladoc reported revenue of $641 million, in line with analysts' expectations. However, the company posted a smaller-than-anticipated loss of $0.19 per share, beating estimates and fueling the stock rally.
Following the results, some analysts slightly raised their earnings forecasts for 2025, but maintained a cautious stance on the company's prospects. Deutsche Bank, for instance, lifted its price target on Teladoc to $12 from $10 but kept a "Hold" rating, citing uncertainty over the company's future performance.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。